Lucentis: Clinical Trials

23 trials of Lucentis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 8 unknown, 1 terminated, 1 withdrawn. 23 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable23Completed 13, Unknown 8, Terminated 1, Withdrawn 1

Follow Lucentis: new trials by email Literature Review of Lucentis trials Research Report on Lucentis

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery
Ranibizumab - Wet Macular Degeneration, Cataract Extraction
Not applicableUnknownOphthalmica Eye Institute162018-01-012019-05-09
Serum Vascular Endothelial Growth Factor in Infants With Intravitreal Ranibizumab
intravitreal ranibizumab - Infant, Premature, Diseases
Not applicableCompletedXinhua Hospital, Shanghai Jiao Tong University School of Medicine172017-05-012018-10-12
Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO
Ranibizumab combined macular laser, Ranibizumab - Branch Retinal Vein Occlusion, Ranibizumab
Not applicableCompletedBeijing Hospital802017-02-142022-12-28
Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy
ranibizumab, sham, pars plana vitrectomy - Proliferative Diabetic Retinopathy
Not applicableCompletedSun Yat-sen University902014-07-012017-10-16
A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy.
Ranibizumab, Aflibercept - Age Related Macular Degeneration
Not applicableCompletedKing's College Hospital NHS Trust592014-06-012021-04-30
Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration
ranibizumab - Exudative Age-related Macular Degeneration
Not applicableUnknownMie University502014-06-012014-12-31
Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion
Ranibizumab - Researcher-Subject Relations
Not applicableCompletedSt. Marianna University School of Medicine502014-03-012017-08-25
Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion
ranibizumab - Macular Edema, Branch Retinal Vein Occlusion
Not applicableUnknownTokyo Medical University1002013-12-012014-06-23
Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration
Iray, Lucentis - Retinal Pigment Epithelial Detachment With Vascularization, Age Related Macular Degeneration
Not applicableUnknownOraya Therapeutics, Inc.122012-08-012012-10-25
Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival
Xylocaine 2% Injectable Anesthetic, Proparacaine Hydrochloride 0.5% Drop, Tetravisc 0.5% Gel - Age-related Macular Degeneration, Central Retinal Vein Occlusion
Not applicableCompletedRetina Vitreous Associates of Florida572012-07-012014-04-21
Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter
Intravitreal Ranibizumab, Intravitreal bevacizumab - Age Related Macular Degeneration
Not applicableUnknownUniversity of Malaya302012-04-012012-06-22
Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes
Ranibizumab - Age Related Macular Degeneration
Not applicableCompletedMcMaster University702012-01-012016-03-17
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
Avastin, Lucentis - Exudative Macular Degeneration, Diabetic Macular Edema
Not applicableCompletedVitreo-Retinal Associates, Michigan162011-11-012014-12-17
Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)
Ranibizumab, Ranibizumab Injection - Age-Related Macular Degeneration
Not applicableUnknownRussian Academy of Medical Sciences3002011-10-012012-08-31
Treatment of Epiretinal Membranes With Ranibizumab
intravitreal ranibizumab - Epiretinal Membrane
Not applicableCompletedQueen's University112010-11-012016-01-13
An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)
Ranibizumab 0.5 mg - Macular Edema, Retinal Vein Occlusion
Not applicableCompletedGenentech, Inc.6082008-07-012012-01-10
Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery
Ranibizumab - Glaucoma
Not applicableTerminatedUniversity of California, San Francisco112008-04-012022-08-02
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)
Ranibizumab, Laser photocoagulation - Macular Edema
Not applicableCompletedKlinikum Ludwigshafen302007-11-012011-07-22
Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy
Ranibizumab - Choroidal Neovascularization
Not applicableCompletedVision Research Foundation402007-10-012012-06-28
Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration
ranibizumab - Age-related Macular Degeneration
Not applicableCompletedPrince of Songkla University252007-08-012011-04-15

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Macular Degeneration (9)  ·  Macular Edema (4)  ·  Retinal Vein Occlusion (4)  ·  Wet Macular Degeneration (2)  ·  Choroidal Neovascularization (1)  ·  Epiretinal Membrane (1)  ·  Glaucoma (1)  ·  Infant, Premature, Diseases (1)  ·  Pain (1)  ·  Retinopathy of Prematurity (1)  ·  Vision Disorders (1)

Sponsors

Barnes Retina Institute (1)  ·  Beijing Hospital (1)  ·  Genentech, Inc. (1)  ·  King's College Hospital NHS Trust (1)  ·  Klinikum Ludwigshafen (1)  ·  Lahey Clinic (1)  ·  McMaster University (1)  ·  Mie University (1)  ·  Ophthalmica Eye Institute (1)  ·  Oraya Therapeutics, Inc. (1)  ·  Prince of Songkla University (1)  ·  Queen's University (1)  ·  Retina Vitreous Associates of Florida (1)  ·  Russian Academy of Medical Sciences (1)  ·  Sheba Medical Center (1)

Countries

United States (5)  ·  China (3)  ·  Canada (2)  ·  Japan (2)  ·  Belgium (1)  ·  Germany (1)  ·  Greece (1)  ·  Israel (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Russia (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Ehud Rechtman, MD (1)  ·  Gaurav K. Shah, MD (1)  ·  Hidetaka Noma, MD (1)  ·  Hongping Xia, MD. PhD (1)  ·  Jeffrey Gale, MD (1)  ·  Jeffrey L Marx, M.D. (1)  ·  Jiro Kogo, M.D., Ph. D. (1)  ·  Lars-Olof Hattenbach, MD, Privatdozent (1)  ·  Lin Lu (1)  ·  Louis C. Glazer, MD (1)  ·  Mariya Budzinskaya, MD, PhD (1)  ·  Michael T Trese, MD (1)  ·  Mineo Kondo (1)  ·  Paris G Tranos, PhD (1)  ·  Patama Bhurayanontachai, MD (1)

Results publications

PMID 17021318, PMID 17021319, PMID 22712537, PMID 25042729, PMID 32560639